# Allstate Corporation (ALL) - Earnings Validation Framework

**Posición:** €400 (4% portfolio), 2 shares @ $197.65 USD
**Earnings Date:** Feb 5, 2026 (Q4 2025)
**Thesis Original:** thesis/research/ALL/thesis.md

---

## Thesis Summary

**Core thesis:**
- P&C insurance US #2 homeowners (8.9%), #4 auto (10.4%)
- **P/E 6.3x = 72% más barato que Admiral UK** (P/E 22.8x) con quality comparable
- **ROE 37%** exceptional, **combined ratio 80%** Q3 2025 (vs industry 95%)
- Turnaround completado: De pérdidas 2022 → $3.7B net income Q3 2025
- Management buybacks agresivos $42.8B desde 1995, dividendo 33 años consecutivo
- Margen seguridad 20-30%

**Key risks:**
- Moat narrow (pricing power limitado, switching costs bajos, commodity product)
- Competencia intensa: Progressive/GEICO pricing más bajo
- CAT exposure: Hurricanes/wildfires pueden spike combined ratio
- 2026 industry outlook: NCR 107-111% (competitive pressure)

**Valuation:**
- Fair value: $240-270 (margen seguridad 22-37%)
- P/E 6.3x vs sector 12.9x = 51% descuento

---

## Métricas Críticas a Verificar (Q4 2025)

### 1. Earnings Quality - Q4 2025

| Métrica | Target Thesis | Threshold HOLD | Threshold CONCERN |
|---------|--------------|----------------|-------------------|
| **Net income Q4** | $900M-1.2B | ≥$800M ✅ | <$700M ⚠️ |
| **EPS Q4** | $2.80-3.50 | ≥$2.50 ✅ | <$2.00 ⚠️ |
| **ROE (annual)** | 35-40% | ≥30% ✅ | <25% ⚠️ |
| **Combined Ratio Q4** | 85-90% | <92% ✅ | >95% ⚠️ |
| **Combined Ratio FY2025** | 86-88% | <90% ✅ | >92% ⚠️ |

**Context:** Q3 2025 combined ratio 80.1% = exceptional. Q4 debe validar sustainability.

### 2. Combined Ratio Breakdown - CRITICAL

| Línea | Target Q4 | Excellent ✅ | Acceptable ✓ | Concern ⚠️ |
|-------|-----------|--------------|--------------|------------|
| **Auto combined ratio** | 82-86% | <85% | 85-90% | >92% |
| **Homeowners combined ratio** | 75-85% | <80% | 80-88% | >90% |
| **Property-Liability total** | 84-88% | <86% | 86-91% | >93% |

**Q3 2025 actual:** Auto 82% (improved 12.8 pts YoY), overall 80.1%.
**Validate:** Q4 no worse than Q3 + guidance 2026 mid-90s realistic.

### 3. CAT Losses - Exposure Management

| Item | Good ✅ | Elevated ⚠️ | Disaster ❌ |
|------|---------|-------------|-------------|
| **CAT losses Q4** | <$400M | $400-600M | >$700M |
| **CAT losses FY2025** | <$2.0B | $2.0-2.5B | >$3.0B |
| **Reinsurance coverage** | Adequate, renewals OK | Premium increases | Coverage reduced |

**Context:** Q4 2025 incluye hurricane season final. Si CAT losses bajo = exceptional year, si alto = test de thesis.

### 4. Pricing & Retention - Moat Test

| Métrica | Strong ✅ | Weakening ⚠️ | Broken ❌ |
|---------|-----------|--------------|-----------|
| **PIF (Policies in Force) growth** | +2-4% | 0-2% | Negative |
| **Retention rate** | >88% | 85-88% | <85% |
| **Average premium auto** | +5-7% | +2-5% | Flat/negative |
| **Market share** | Stable 10.4% auto, 8.9% home | -0.2pp | -0.5pp+ |

**Critical:** Si PIF growth negativo = losing pricing power, competidores winning.

### 5. Guidance 2026 - Sustainability Test

| Guidance Item | Bullish ✅ | Neutral ✓ | Bearish ⚠️ |
|--------------|-----------|-----------|------------|
| **Combined ratio 2026** | <90% | 90-95% | >95% |
| **ROE target 2026** | >30% | 25-30% | <25% |
| **EPS guidance** | >$12 | $10-12 | <$10 |

**Context:** Management guided mid-90s auto combined ratio 2026. Validate realistic.

---

## Triggers de Decisión Post-Earnings

### ACCIÓN: HOLD (más probable)

**Condiciones:**
- ✅ Combined ratio Q4 <92%, FY2025 <90%
- ✅ ROE annual >30%
- ✅ CAT losses Q4 reasonable (<$500M)
- ✅ PIF growth positive, retention >87%
- ✅ Guidance 2026: Combined ratio mid-90s, ROE >25%

**Razonamiento:**
- Thesis validada: Turnaround sostenible, no fluke 2025
- Moat narrow PERO execution exceptional compensa
- P/E 6.3x con ROE 30%+ = value extremo
- 72% discount vs Admiral justificado SOLO si execution continúa

**Portfolio impact:** Defensive 15% mantiene (Allstate 4%)

---

### ACCIÓN: ADD €300-400 (4% → 7-8% total)

**Condiciones:**
- ✅ Combined ratio Q4 <85%, FY2025 <88% (BEAT expectations)
- ✅ ROE annual >35% (maintains Q3 level)
- ✅ CAT losses Q4 <$300M (excellent risk management)
- ✅ PIF growth >3%, retention >88%
- ✅ Guidance 2026 BULLISH: Combined ratio <92%, ROE >30%
- ✅ Stock reaction muted (P/E stays <8x post-earnings)

**Razonamiento:**
- Execution EXCEPTIONAL validado
- Moat narrow PERO quality comparable Admiral a 1/3 precio
- 72% discount injustificado si combined ratio sostenible <90%
- Cierra gap defensive: 15% → 18-19%

**Portfolio impact:**
- Defensive: 15% → 18-19%
- Insurance sector: 4% → 7-8% (OK <10%)
- Cash post-ADD: €5,100 (51%) OK

**Risk:** Aumenta concentración insurance PERO P&C diferente healthcare (CVS watchlist).

---

### ACCIÓN: TRIM 50% (€400 → €200)

**Condiciones:**
- ⚠️ Combined ratio Q4 92-96% (deterioration vs Q3 80%)
- ⚠️ ROE annual 25-30% (down from 37% Q3)
- ⚠️ CAT losses Q4 >$600M (elevated, not disaster)
- ⚠️ PIF growth 0-1% (competitive pressure)
- ⚠️ Guidance 2026: Combined ratio 95-100% (industry average)

**Razonamiento:**
- Thesis weakening: Q3 was peak, mean reversion happening
- Combined ratio reverting to industry 95% = P/E 6.3x menos attractive
- Moat narrow + competitive pressure increasing
- Reduce exposure, mantiene parcial por value residual

**Portfolio impact:**
- Defensive: 15% → 13%
- Libera €200 para mejores oportunidades

**Siguiente:** Re-evaluar Q1 2026 earnings antes de exit completo

---

### ACCIÓN: SELL 100% (€400 out)

**Condiciones (al menos 2):**
- ❌ Combined ratio Q4 >100% (underwriting LOSS)
- ❌ ROE annual <20% (collapse from 37%)
- ❌ CAT losses Q4 >$1B (disaster quarter)
- ❌ PIF growth negative (losing customers)
- ❌ Guidance 2026: Combined ratio >105% OR cut dividend
- ❌ Competitive dynamics: Progressive/GEICO pricing war announced

**Razonamiento:**
- Thesis INVALIDADA: Turnaround reversed, execution failing
- Combined ratio >100% = destroying value underwriting
- Moat narrow insufficient to defend vs aggressive competitors
- Better alternative: Admiral UK si cae £24-26 (margen 25%+)

**Capital reallocation:**
- €400 → Cash (esperar oportunidades)
- O → Admiral si precio £24-26 + earnings beat (mar 5)

---

## Comparación Competitiva Post-Earnings

**Validate Allstate vs Admiral UK (earnings Mar 5):**

| Métrica | Allstate | Admiral UK | Better |
|---------|----------|------------|--------|
| **P/E** | 6.3x | 22.8x | ALL ✅ 72% cheaper |
| **ROE** | 37% (validate) | 56% | ADM ✅ |
| **Combined ratio** | 80% Q3 (validate Q4) | 77% | ADM ✅ |
| **Moat** | Narrow | Narrow | Tie |
| **Execution** | Exceptional 2025 (validate) | Consistent | TBD |
| **Risk 2026** | NCR 107-111% pressure | Aviva+DL merger threat | Both ⚠️ |

**Conclusión:**
- Si Allstate combined ratio Q4 <90% + ROE >30% → **ADD Allstate** (better value 72% discount)
- Si Allstate deteriorates Q4 + Admiral beats Mar 5 → **TRIM Allstate**, wait Admiral £24-26
- Si ambos deterioran → **Insurance sector difficult 2026**, reduce exposure both

---

## Checklist Post-Earnings (Feb 5)

**Inmediatamente después earnings release:**

- [ ] Leer earnings release completo
- [ ] Verificar métricas críticas: Combined ratio, ROE, CAT losses
- [ ] Verificar PIF growth + retention rate
- [ ] Leer guidance 2026 (combined ratio target CRITICAL)
- [ ] Verificar dividend confirmed (33 años consecutivo)

**Earnings call (same day):**

- [ ] Escuchar earnings call (o leer transcript)
- [ ] Q&A sobre combined ratio sustainability
- [ ] Q&A sobre competitive dynamics 2026 (Progressive/GEICO)
- [ ] Q&A sobre CAT reinsurance renewals
- [ ] Q&A sobre pricing power + retention strategy

**Análisis (1-2 días post):**

- [ ] Verificar reacción mercado (¿P/E stays <8x?)
- [ ] Leer 3-5 analyst notes (focus combined ratio sustainability)
- [ ] Comparar vs peers: Progressive, GEICO results (si disponibles)
- [ ] Actualizar thesis/research/ALL/thesis.md
- [ ] Decidir acción: HOLD / ADD / TRIM / SELL

**Si decisión = ADD o SELL:**

- [ ] Ejecutar operación en eToro
- [ ] Actualizar portfolio/current.yaml
- [ ] Calcular impacto defensive % (15% → 18% si ADD, → 13% si TRIM)
- [ ] Informar usuario con resumen ejecutivo

---

## Contexto Macro Relevante

**P&C Insurance industry 2026:**
- NCR (Net Combined Ratio) consensus: 107-111% = competitive
- Pricing pressure after strong 2024-25 (industry recovered from CAT losses 2022-23)
- Competitive dynamics: Progressive gaining share, GEICO recovering

**CAT exposure:**
- Climate change → higher CAT frequency expected
- Reinsurance costs increasing 2025-26
- California/Florida exposure particularly elevated

**Portfolio context:**
- Gap defensive 20-25% (Allstate 4% de 35-40% target)
- Si ADD Allstate → cierra gap parcial defensive
- Insurance P&C sector <10% OK (current 4%, ADD llevaría a 7-8%)

**Admiral UK context (watchlist):**
- Earnings Mar 5 (1 mes post-Allstate)
- Si Admiral beats + Allstate meets → compara value 72% discount
- Si Admiral misses + Allstate beats → Allstate superior confirmed

---

**PREPARED:** 2026-01-30
**NEXT REVIEW:** Post-earnings Feb 5, 2026
**DECISION DEADLINE:** Feb 6-7 (mismo día Shell earnings, decidir prioridades)
**CROSS-CHECK:** Admiral UK earnings Mar 5 (validate comparative)